Activ Surgical, a Boston, MA-based digital intelligence company focused on improving surgical efficiency, accuracy, patient outcomes and accessibility, closed an additional $11m in Series A funding.
The round was led by DNS Capital, with participation from GreatPoint Ventures (GPV), Tao Capital Partners, SONY Innovation Fund, Rising Tide Financial, WS Investment Company and Mintz.
The company intends to use the funds to accelerate commercialization of its proprietary, software-centric and hardware agnostic technology.
Founded in 2017 and led by Todd Usen, Chief Executive Officer, Activ Surgical is a digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes and accessibility for both endoscopic and robotically-assisted procedures. Its patent-protected surgical software platform technology is driven by computer vision, artificial intelligence, analytics and machine learning to enhance a surgeon’s intra-operative decision making, and reduce unintended and preventable surgical complications.
ActivSight (the company’s first planned commercial launch in fall 2020) is an advanced software and sensing platform which works dynamically and seamlessly to “ACTIVATE” any installed base of surgical visualization and robotics systems to provide real time intraoperative visual data and images not currently available to surgeons through existing technologies.